Red Cell Distribution Width as a Predictor of Mortality in Acute Methanol Poisoning

Methanol Poisoning Clinical Trial

Official title:

Red Cell Distribution Width as a Predictor of Mortality in Acute Methanol Poisoning

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04064801
• Other study ID #: AdanaCTYHOSP
• Status: Completed
• Start date: March 15, 2020
• Est. completion date: August 30, 2020

Study information

• Verified date: April 2021
• Source: Adana Numune Training and Research Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The study aimed to investigate the association between RDW and in-hospital mortality in methanol poisoning.

Description:

RDW values have been found to be an independent predictor of the prognosis among patients with heart diseases, stroke,community-acquired pneumonia (CAP), pulmonary embolism, chronic obstructive pulmonary disease (COPD), septic shock, and acute pancreatitis.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 42
• Est. completion date: August 30, 2020
• Est. primary completion date: May 30, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

All patients aged =18 years who were admitted to emergency departments from January 2019 to January 2020 on account of acute methanol intoxication.

Exclusion Criteria:

Incomplete data, Malignancy, Severe anaemia, History of erythrocyte transfusion last 6 weeks

-

Related Conditions & MeSH terms

• Methanol Poisoning
• Poisoning

Locations

Country	Name	City	State
Turkey	Adana City Training and Research Hospital	Adana

Sponsors (1)

Lead Sponsor	Collaborator
Adana Numune Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Hospital mortality		7 day
Primary	Need for mechanical ventilation		7 day